Carles Galdeano

2.1k total citations
35 papers, 1.6k citations indexed

About

Carles Galdeano is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Carles Galdeano has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Carles Galdeano's work include Cholinesterase and Neurodegenerative Diseases (13 papers), Protein Degradation and Inhibitors (10 papers) and Computational Drug Discovery Methods (8 papers). Carles Galdeano is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (13 papers), Protein Degradation and Inhibitors (10 papers) and Computational Drug Discovery Methods (8 papers). Carles Galdeano collaborates with scholars based in Spain, United Kingdom and Italy. Carles Galdeano's co-authors include Alessio Ciulli, Morgan S. Gadd, Pedro Soares, Diego Muñoz‐Torrero, F. Javier Luque, David M. Dias, Inge Van Molle, Elisabet Viayna, Pelayo Camps and Salvatore Scaffidi and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Carles Galdeano

34 papers receiving 1.6k citations

Peers

Carles Galdeano
Xueyang Jiang China
Daniela Pizzirani Italy
Elisabetta Orlandini Italy
Rita Scarpelli Italy
Susanna Nencetti Italy
Keren Wang China
Roger E. Markwell United Kingdom
Hubert Josien United States
Huiping Zhao United States
Yuanjun He United States
Xueyang Jiang China
Carles Galdeano
Citations per year, relative to Carles Galdeano Carles Galdeano (= 1×) peers Xueyang Jiang

Countries citing papers authored by Carles Galdeano

Since Specialization
Citations

This map shows the geographic impact of Carles Galdeano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Galdeano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Galdeano more than expected).

Fields of papers citing papers by Carles Galdeano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carles Galdeano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Galdeano. The network helps show where Carles Galdeano may publish in the future.

Co-authorship network of co-authors of Carles Galdeano

This figure shows the co-authorship network connecting the top 25 collaborators of Carles Galdeano. A scholar is included among the top collaborators of Carles Galdeano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carles Galdeano. Carles Galdeano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scaffidi, Salvatore, S. Picaud, T. Krojer, et al.. (2025). Water Networks as Hydrophobic Recognition Motifs in Proteins. Angewandte Chemie International Edition. 65(2). e21138–e21138. 1 indexed citations
2.
Escudero, C. Iglesias, Tian V. Tian, Dmytro S. Radchenko, et al.. (2025). A bottom-up approach to find lead compounds in expansive chemical spaces. Communications Chemistry. 8(1). 225–225.
3.
Pérez, Coralia, Mikel Azkargorta, Ibón Iloro, et al.. (2025). Cullin-RING ligase BioE3 reveals molecular-glue-induced neosubstrates and rewiring of the endogenous Cereblon ubiquitome. Cell Communication and Signaling. 23(1). 101–101. 2 indexed citations
4.
Busquets, Maria Antònia, et al.. (2024). Proximity-Induced Pharmacology for Amyloid-Related Diseases. Cells. 13(5). 449–449. 4 indexed citations
5.
Galdeano, Carles, et al.. (2024). Drug Discovery Approaches to Target E3 Ligases. ChemBioChem. 26(1). e202400656–e202400656. 9 indexed citations
6.
Barroso, Emma, Andreea L. Turcu, Patricia Rada, et al.. (2023). Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress. Biomedicine & Pharmacotherapy. 168. 115667–115667. 4 indexed citations
7.
Griñán‐Ferré, Christian, Jun Yang, Rosana Leiva, et al.. (2020). Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease. Neurotherapeutics. 17(4). 1825–1835. 49 indexed citations
8.
Estarellas, Carolina, Salvatore Scaffidi, Giorgio Saladino, et al.. (2019). Modulating Ligand Dissociation through Methyl Isomerism in Accessory Sites: Binding of Retinol to Cellular Carriers. The Journal of Physical Chemistry Letters. 10(23). 7333–7339. 4 indexed citations
9.
Hyroššová, Petra, Albert Figueras, Francesc Viñals, et al.. (2019). Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M. Biomedicine & Pharmacotherapy. 121. 109601–109601. 11 indexed citations
10.
Scaffidi, Salvatore, et al.. (2019). Hydrophobic Waters in Bromodomains. SHILAP Revista de lepidopterología. 80–80. 1 indexed citations
11.
Galdeano, Carles, Nicolas Coquelle, Manuela Bartolini, et al.. (2018). Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules. 23(3). 634–634. 31 indexed citations
12.
Frost, Julianty, Carles Galdeano, Pedro Soares, et al.. (2016). Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition. Nature Communications. 7(1). 13312–13312. 178 indexed citations
13.
Sola, Irene, Elisabet Viayna, Carles Galdeano, et al.. (2015). Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal–antiplasmodial activity. Bioorganic & Medicinal Chemistry. 23(16). 5156–5167. 13 indexed citations
14.
Pietro, Ornella Di, Alba Espargaró, Anna Vallverdú‐Queralt, et al.. (2014). Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties. Bioorganic & Medicinal Chemistry. 22(19). 5298–5307. 37 indexed citations
15.
Espargaró, Alba, et al.. (2014). Thioflavin-S Staining of Bacterial Inclusion Bodies for the Fast, Simple, and Inexpensive Screening of Amyloid Aggregation Inhibitors. Current Medicinal Chemistry. 21(9). 1152–1159. 40 indexed citations
16.
Juárez‐Jiménez, Jordi, Eduarda Mendes, Carles Galdeano, et al.. (2013). Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: Role of Asn181 and Ile335 validated by spectroscopic and computational studies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(2). 389–397. 15 indexed citations
17.
Muñoz‐Torrero, Diego, Marta Pera, Carles Galdeano, et al.. (2012). Expanding the Multipotent Profile of Huprine-Tacrine Heterodimers as Disease-Modifying Anti-Alzheimer Agents. Neurodegenerative Diseases. 10(1-4). 96–99. 5 indexed citations
18.
Formosa, X., Carles Galdeano, Martin C. Taylor, et al.. (2011). Huprines as a new family of dual acting trypanocidal–antiplasmodial agents. Bioorganic & Medicinal Chemistry. 19(5). 1702–1707. 8 indexed citations
19.
Galdeano, Carles, Elisabet Viayna, Pau Arroyo, et al.. (2010). Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents. Current Pharmaceutical Design. 16(25). 2818–2836. 49 indexed citations
20.
Camps, Pelayo, X. Formosa, Carles Galdeano, et al.. (2010). Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates. Chemico-Biological Interactions. 187(1-3). 411–415. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueyang Jiang Breakdown of academic impact, for papers by Daniela Pizzirani Breakdown of academic impact, for papers by Elisabetta Orlandini Breakdown of academic impact, for papers by Rita Scarpelli Breakdown of academic impact, for papers by Susanna Nencetti Breakdown of academic impact, for papers by Keren Wang Breakdown of academic impact, for papers by Roger E. Markwell Breakdown of academic impact, for papers by Hubert Josien Breakdown of academic impact, for papers by Huiping Zhao Breakdown of academic impact, for papers by Yuanjun He
Rankless by CCL
2026